Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Keratosis, Actinic 5Neoplasms 2Neoplasm Metastasis 2Melanoma 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors Harboring NTRK Fusion 1Small Cell Lung Carcinoma 1Seizures 1Prostatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, T-Cell 1Lung Neoplasms 1Leukemia 1Lennox Gastaut Syndrome 1Head and Neck Neoplasms 1Epilepsies, Myoclonic 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Anemia 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1

Interventions

Epoetin Alfa 38Darbepoetin alfa 30epoetin beta 10peginesatide 3luspatercept 3hematide 3ACE-011 3telapristone acetate 2ferric carboxymaltose 2Erythropoietin 2AP 1903 reagent 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2roxadustat 1iron isomaltoside 1000 1ferrous sulfate 1ferric gluconate 1continuous erythropoietin receptor activator 1angiotensin I (1-7) 1Sugars 1Standard of Care 1Solutions 1Population Groups 1NOX-H94 1Lenalidomide 1LY2787106 1Iron-Dextran Complex 1Injections 1Infliximab 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Anemia × Solutions × Clear all
NCT00711958 2017-09-05

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Sandoz

Phase 3 Completed
114 enrolled 10 charts
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡